In the 1950s, Diapulse established research in the U.S. and at international universities and hospitals. The Diapulse effectively addresses three basic processes involved in healing, i.e., elimination of edema, absorption of hematoma and increased blood-flow.
In 1958, the Mayo Clinic confirmed studies previously carried out by Ginsberg demonstrating the cellular effects of pulsed electromagnetic energy known as Pearl-Chain phenomena. “A 1962 study of Diapulse in the treatment of pelvic inflammatory disease reported an average hospital stay of 7.4 days for Diapulse treated patients versus 13.5 days in the control group.” “A 1966 placebo controlled study of tonsillectomies demonstrated a 50% reduction in hospital stay for the Diapulse treated group.” “A 1969 report from Tel Aviv University Department of Plastic Surgery reviewed cases of soldiers requiring reconstructive surgery at the end of the six-day war in June 1967. Through the use of Diapulse hospitalization was reduced by 25%.” All in all, more than 15 U.S. and international university and medical hospitals had conducted tests showing Diapulse had reduced hospital stays by 50% and helped attain neurological improvement, when none had been present previously. All these studies were done before the Diapulse was banned as a quack device.
“A study of Diapulse on spinal cord injury conducted in Poland in the late 1970’s, 97 patients underwent treatment. A pronounced neurological recovery was observed in 40% of the patients where they were discharged from the Neuro-orthopedic Department. The non-treated control group had no patients discharged.” “At New York University Medical Center in the early 1980’s’ Diapulse was used on cats with induced spinal crush injuries. Dr. Young, Director of Neurosurgical Research reported that 7 of 9 cats receiving the Diapulse at 4 hours after injury, recovered walking in 4 months, compared with 0 of 10 of the sham treated group.”
“Accelerated healing of burn victims was significant. In a report of 2,000 patients covering 9 years, results were described as significant for the immediate relief of pain. One attempt to confirm those observations with the rigor of a double blind study was aborted when nurses involved in the study refused to participate after 3 days. It was so apparent which patients were receiving the placebo machine.”
In a court trial, the Diapulse won against the FDA in the late 1980s. The FDA claimed the Diapulse was mislabeled because nothing was capable of accelerating healing, therefore it was mislabeled. The documentation presented to the court by Diapulse, was so overwhelming, that the FDA was forced to immediately stop the ban and announce in 1990 that Diapulse was a new emerging technology. The Diapulse had been banned in the U.S. for 18 years but sold in other countries around the world.
In my consulting capacity with Mutual Benefit Life Insurance, I suggested that the company examine the Diapulse. Dr. Tarasenko, Director of Medical Services treated a variety of medical issues for nearly 1,000 employees. He was so impressed, he prepared a paper on 40 cases and presented it at a national meeting for occupational medicine. “One of his more celebrated cases was that of a senior executive for a competitor insurance company. The officer was disabled, working only 2 hours per week and unable to take a business trip because of excruciating pain. He had a double laminectomy, nerve block, and etc. etc. all with no relief. In two weeks treatment with Diapulse, he was back at work full time, taking business trips. His company’s Medical Director purchased a Diapulse machine for its employees.”
Energy medicine, in this case electromagnetics, has a wonderful history in healing. More than 40 prestigious worldwide institutions have demonstrated that this device accelerated healing between 40 and 50%. Many of these institutions were carrying on research during the FDA ban. The device never touches the body but sends the energy through the air. Today there are numerous devices that utilize electromagnetism in the healing process. I thought I would share a bit of history.